NR3C2 and hyperaldosteronism: In this context, hyperaldosteronism has been linked clinically to an increased risk of ventricular arrhythmias and sudden death, independently of the blood pressure or serum potassium concentration, plenty justifying the utilization of MR antagonists like spironolactone and eplerenone in the treatment of cardiac failure.